Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial

Background and Objectives: Diarrhea induced by chemotherapy may represent a life-threatening adverse effect in cancer patients receiving chemotherapy. FOLFOX, an effective treatment for colon cancer, has been associated with diarrhea with high severity, particularly with higher doses. Management of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabry, Nesreen M., Naguib, Tamer M., Kabel, Ahmed M., Khafagy, El-Sayed, Arab, Hany H., Almorsy, Walid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955640/
https://www.ncbi.nlm.nih.gov/pubmed/35334570
http://dx.doi.org/10.3390/medicina58030394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955640/
https://www.ncbi.nlm.nih.gov/pubmed/35334570
http://dx.doi.org/10.3390/medicina58030394

Ejemplares similares